执行摘要：益生菌作为食品和药物开发的科学与监管挑战 - Suppr

Suppr

超能文献

Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs.

作者信息

Hoffman Freddie Ann, Heimbach James T, Sanders Mary Ellen, Hibberd Patricia L

机构信息

HeteroGeneity, Washington, DC 20011, USA.

出版信息

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S53-7. doi: 10.1086/523342.

DOI:10.1086/523342

PMID:18181723

Abstract

摘要

相似文献

Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S53-7. doi: 10.1086/523342.

Regulation of probiotic substances as ingredients in foods: premarket approval or "generally recognized as safe" notification.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S115-8; discussion S144-51. doi: 10.1086/523329.

Probiotic foods and drugs: impact of US regulatory status on design of clinical trials.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S137-40; discussion S144-51. doi: 10.1086/523321.

Business considerations in the development of probiotics.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S141-3; discussion S144-51. doi: 10.1086/523323.

The Probiotic Conundrum: Regulatory Confusion, Conflicting Studies, and Safety Concerns.

JAMA. 2020 Mar 3;323(9):823-824. doi: 10.1001/jama.2019.22268.

Clinical research on probiotics: the interface between science and regulation.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S101-3; discussion S144-51. doi: 10.1086/523332.

Current marketplace for probiotics: a Japanese perspective.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S73-5; discussion S144-51. doi: 10.1086/523338.

Probiotics in the United States.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S67-72; discussion S144-51. doi: 10.1086/523339.

Environmental assessment requirements for live biological drugs.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S112-4; discussion S144-51. doi: 10.1086/523330.

Allergen-free probiotics.

J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 2:S201-4. doi: 10.1097/MCG.0b013e31818063ed.

引用本文的文献

Nutraceuticals in Pregnancy: A Special Focus on Probiotics.

Int J Mol Sci. 2024 Sep 7;25(17):9688. doi: 10.3390/ijms25179688.

How does a extract influence the components of isolated rotavirus particles from stool samples collected in a clinical setting from children?

Saudi J Biol Sci. 2024 Aug;31(8):104031. doi: 10.1016/j.sjbs.2024.104031. Epub 2024 May 26.

Probiotics During the Therapeutic Management of Periodontitis.

Adv Exp Med Biol. 2022;1373:353-375. doi: 10.1007/978-3-030-96881-6_19.

Composition and Laboratory Correlation of Commercial Probiotics in India.

Cureus. 2020 Nov 5;12(11):e11334. doi: 10.7759/cureus.11334.

Cell-bound Exopolysaccharide Extract from Indigenous Probiotic Bacteria Induce Apoptosis in HT-29 cell-line.

Iran J Pathol. 2019 Winter;14(1):41-51. doi: 10.30699/IJP.14.1.41. Epub 2018 Dec 27.

Lactic Acid Bacteria and Their Bacteriocins: Classification, Biosynthesis and Applications against Uropathogens: A Mini-Review.

Molecules. 2017 Jul 26;22(8):1255. doi: 10.3390/molecules22081255.

Effects of the probiotic Bifidobacterium animalis subsp. lactis on the non-surgical treatment of periodontitis. A histomorphometric, microtomographic and immunohistochemical study in rats.

PLoS One. 2017 Jun 29;12(6):e0179946. doi: 10.1371/journal.pone.0179946. eCollection 2017.

The efficacy and safety of adding the probiotic Saccharomyces boulardiito standard triple therapy for eradication of H.pylori: a randomized controlled trial.

Gastroenterol Hepatol Bed Bench. 2013;6(Suppl 1):S99-S104.

Clinical update for the diagnosis and treatment of Clostridium difficile infection.

World J Gastrointest Pharmacol Ther. 2014 Feb 6;5(1):1-26. doi: 10.4292/wjgpt.v5.i1.1.

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis.

Aliment Pharmacol Ther. 2014 May;39(10):1113-25. doi: 10.1111/apt.12695. Epub 2014 Mar 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs.

作者信息

Hoffman Freddie Ann, Heimbach James T, Sanders Mary Ellen, Hibberd Patricia L

机构信息

HeteroGeneity, Washington, DC 20011, USA.

出版信息

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S53-7. doi: 10.1086/523342.

DOI:10.1086/523342

PMID:18181723

Abstract

摘要

相似文献

Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S53-7. doi: 10.1086/523342.

Regulation of probiotic substances as ingredients in foods: premarket approval or "generally recognized as safe" notification.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S115-8; discussion S144-51. doi: 10.1086/523329.

Probiotic foods and drugs: impact of US regulatory status on design of clinical trials.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S137-40; discussion S144-51. doi: 10.1086/523321.

Business considerations in the development of probiotics.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S141-3; discussion S144-51. doi: 10.1086/523323.

The Probiotic Conundrum: Regulatory Confusion, Conflicting Studies, and Safety Concerns.

JAMA. 2020 Mar 3;323(9):823-824. doi: 10.1001/jama.2019.22268.

Clinical research on probiotics: the interface between science and regulation.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S101-3; discussion S144-51. doi: 10.1086/523332.

Current marketplace for probiotics: a Japanese perspective.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S73-5; discussion S144-51. doi: 10.1086/523338.

Probiotics in the United States.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S67-72; discussion S144-51. doi: 10.1086/523339.

Environmental assessment requirements for live biological drugs.

Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S112-4; discussion S144-51. doi: 10.1086/523330.

Allergen-free probiotics.

J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 2:S201-4. doi: 10.1097/MCG.0b013e31818063ed.

引用本文的文献

Nutraceuticals in Pregnancy: A Special Focus on Probiotics.

Int J Mol Sci. 2024 Sep 7;25(17):9688. doi: 10.3390/ijms25179688.

How does a extract influence the components of isolated rotavirus particles from stool samples collected in a clinical setting from children?

Saudi J Biol Sci. 2024 Aug;31(8):104031. doi: 10.1016/j.sjbs.2024.104031. Epub 2024 May 26.

Probiotics During the Therapeutic Management of Periodontitis.

Adv Exp Med Biol. 2022;1373:353-375. doi: 10.1007/978-3-030-96881-6_19.

Composition and Laboratory Correlation of Commercial Probiotics in India.

Cureus. 2020 Nov 5;12(11):e11334. doi: 10.7759/cureus.11334.

Cell-bound Exopolysaccharide Extract from Indigenous Probiotic Bacteria Induce Apoptosis in HT-29 cell-line.

Iran J Pathol. 2019 Winter;14(1):41-51. doi: 10.30699/IJP.14.1.41. Epub 2018 Dec 27.

Lactic Acid Bacteria and Their Bacteriocins: Classification, Biosynthesis and Applications against Uropathogens: A Mini-Review.

Molecules. 2017 Jul 26;22(8):1255. doi: 10.3390/molecules22081255.

Effects of the probiotic Bifidobacterium animalis subsp. lactis on the non-surgical treatment of periodontitis. A histomorphometric, microtomographic and immunohistochemical study in rats.

PLoS One. 2017 Jun 29;12(6):e0179946. doi: 10.1371/journal.pone.0179946. eCollection 2017.

The efficacy and safety of adding the probiotic Saccharomyces boulardiito standard triple therapy for eradication of H.pylori: a randomized controlled trial.

Gastroenterol Hepatol Bed Bench. 2013;6(Suppl 1):S99-S104.

Clinical update for the diagnosis and treatment of Clostridium difficile infection.

World J Gastrointest Pharmacol Ther. 2014 Feb 6;5(1):1-26. doi: 10.4292/wjgpt.v5.i1.1.

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis.

Aliment Pharmacol Ther. 2014 May;39(10):1113-25. doi: 10.1111/apt.12695. Epub 2014 Mar 16.